CHONGQING LUMMY PHAR

Discover why Chongqing Lummy Pharmaceutical’s flat trading day hides strong upside—diversified pipeline, robust growth, and solid market fundamentals.

Discover why Chongqing Lummy Pharmaceutical’s pipeline, regulatory advantage, and disciplined capital strategy are driving a strong 67% YTD gain in a market‑challenged environment.

Chongqing Lummy Pharmaceutical: 40% month‑to‑month gain, CNY 9.3 close near all‑time high, diversified pharma pipeline and strong market cap.